Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

NRF2 activator

DRUG CLASS:

NRF2 activator

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

antroquinonol (0)

omaveloxolone (0)

antroquinonol (0)

omaveloxolone (0)

›

PD-L1 expression	Small Cell Lung Cancer	PD-L1 expression	Small Cell Lung Cancer	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3
MRC1 expression	Small Cell Lung Cancer	MRC1 expression	Small Cell Lung Cancer	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3
ER positive + ZNF217 overexpression	HER2 Positive Breast Cancer	ER positive + ZNF217 overexpression	HER2 Positive Breast Cancer	CU01 Sensitive: D – Preclinical CU01 Sensitive : D	CU01 Sensitive: D – Preclinical CU01 Sensitive : D